Mechanistically, METTL3 promotes HCC growth and invasiveness by repressing the expression of suppressor of cytokine signaling 2 (SOCS2), a tumor suppressor in HCC, through m6A-YTHDF2-dependent mRNA degradation. Here, SOCS2 is linked to hepatocellular carcinoma.